Perrigo Ordinary Shares reported $2B in Current Liabilities for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Aphria Inc APH:CN C$ 216.99M 75.99M
Bayer BAYN:GR € 28727M 801M
Bristol Myers Squibb BMY:US $ 21460M 2469M
Catalent CTLT:US $ 1096M 100M
Coherus Biosciences CHRS:US $ 320.35M 33.3M
Corcept Therapeutics CORT:US $ 44.76M 0.64M
Eli Lilly And LLY:US $ 13682M 1411.2M
Endo International Ordinary Shares ENDP:US $ 1554.27M 145.06M
Flexion Therapeutics FLXN:US $ 43.99M 4.06M
Gw Pharmaceuticals GWPH:US $ 160.25M 0.44M
Horizon Pharma HZNP:US $ 854.04M 1.23M
JAZZ PHA JAZZ:US $ 735.05M 145.54M
Lannett LCI:US $ 112.28M 21.81M
Pacira Pharmaceuticals PCRX:US $ 225.79M 2.9M
Perrigo Ordinary Shares PRGO:US $ 2003.8M 19.3M
Phibro Animal Health PAHC:US $ 152.59M 11.53M
Prestige Brands PBH:US $ 148.94M 23.89M
Supernus Pharmaceuticals SUPN:US $ 234.71M 48.74M
Teva Pharmaceutical TEVA:IT 11.82B 866M
Xeris Pharmaceuticals Inc XERS:US $ 37.28M 1.82M
Zoetis ZTS:US $ 1471M 620M